Details

Pubarquia precoz idiopática: Relación con el síndrome metabólico y con el desarrollo de hiperandrogenismo ovárico

by Jaramillo Villegas, Adriana María

Abstract (Summary)
SUMMARY: "PRECOCIUS PUBARCHE: RELATION WITH METABOLIC SYNDROME AND DEVELOPMENT OF OVARIAN HYPERANDROGENISM" TEXT: 1) Background: Precocious pubarche in girls (PP, appearance of pubic hair before 8 yr) is associated with prepuberal hyperinsulinemia and dyslipemia, and with increased incidence of hyperinsulinemic ovarian hyperandrogenism -so called polycystic ovary syndrome (PCOS)-, at adolescence, which has been associated with endothelial dysfunction specially with increased carotid intima-media thickness (IMT)-, and subsequent risk for cardiovascular disease and type 2 diabetes. 2) Aim and hypothesis: We hypothesized that young women with a history of PP show an increased prevalence of common manifestations for PCOS and metabolic syndrome (MS) (hyperglycaemia y/o hyperinsulinemia, dyslipemia, central adiposity, endothelial dysfunction and hypertension); PP patients small for gestational age (SGA) show a higher prevalence of PCOS and metabolic syndrome than those with adequate weight for gestational age (AGA); and women who received metformin and flutamide treatment at adolescence, have less prevalence of common manifestations of PCOS and MS at adulthood. 3) Methods: A case-control study was conducted on 20 young women [age 29,6 ? 3,3 yr; body mass index (BMI): 25,2 ? 4,6] with a history of PP. In all cases, PP had been attributed to an amplified adrenarche, based on high circulating levels of dehydroepiandrosterona sulphate and/or androstenedione for chronological age at diagnosis. Endocrine-metabolic variables, body composition (by dual-energy X-ray absorptiometry), carotid IMT and ovarian morphology by transvaginal ultrasonography were assessed in all women. 4) Results: 1) PP patients showed a 35% prevalence of PCOS (Rotterdam criteria) and a 20% prevalence of MS (International Diabetes Federation). 2) Prevalence of PCOS was higher at adolescence than at adulthood (70% vs 35%). 3) Prevalence of common manifestations for both pathologies was as follows: 45% insulin resistance and/or impaired glucose tolerance; 40% obesity, 35% endothelial dysfunction; 20% dyslipemia and 5% hypertension. 4) PP patients showed a higher carotid IMT in relation to a control group (n=16) of similar characteristics in terms of age and BMI (0,51 ± 0,1 and 0,38 ± 0,07mm, respectively) (p:0,005). 5) Patients SGA (n=4) and AGA (n=16) showed similar prevalence of PCOS and MS. 6) Patients who received metformin and flutamide treatment at adolescence (2-3 years), showed a lower prevalence of PCOS than patients who did not receive this treatment (11% and 64%, respectively), whereas the incidence of MS did not show a significant difference (22% and 18%, respectively). 5) Conclusions: At adulthood, PP patients show alterations that are usually associated to MS and PCOS, independent of the weight at birth. Treatment with metformin and flutamide at adolescence decreases the incidence of PCOS at adulthood. PP patients require clinical and analytical follow-up during adolescence and a later control when they reach adulthood.
This document abstract is also available in Spanish.
Document Full Text
The full text for this document is available in Spanish.
Bibliographical Information:

Advisor:Martín Mateos, María Asunción; Ibáñez Toda, Lourdes

School:Universitat de Barcelona

School Location:Spain

Source Type:Master's Thesis

Keywords:obstetrícia i ginecologia pediatria radiologia medicina física

ISBN:

Date of Publication:07/18/2008

© 2009 OpenThesis.org. All Rights Reserved.